nct_id,trial_id,title,phase,region,sponsor,inclusion,exclusion,notes,source
NCT03049891,T-CT-001,"Pediatric Decentralization of ART in South Africa","Implementation/Observational","South Africa","Local health program / academic","HIV positive; age < 15 years; initiated ART at designated facility during study period","Not started ART before end of specified period; Lost to follow-up before enrolment window","Decentralisation of routine ART services to primary care; pediatric adherence/viral-load endpoints","ClinicalTrials.gov (NCT03049891)"
NCT04038632,T-CT-002,"TB-Speed Decentralisation (childhood TB diagnostic decentralisation)","Implementation / Multi-country","Cambodia; Cameroon; CÃ´te d'Ivoire; Mozambique; Sierra Leone; Uganda","TB-Speed consortium / Unitaid","Child with presumptive pulmonary TB; site-specific pediatric ages","Parent/guardian does not consent to study-specific samples; Severe comorbidity preventing participation","Decentralisation of TB diagnostic capacity to PHC/DH; diagnostic/screening DCT elements","ClinicalTrials.gov / TB-Speed protocol"
NCT05048472,T-CT-003,"East Africa Point of Care Viral Load Study (EAPoC-VL)","Implementation / Feasibility","East Africa","Regional consortium / academic","People receiving ART requiring viral load monitoring; Age >= 18 (site-specific)","Not on ART; Unable/unwilling to consent","Point-of-care decentralised viral load monitoring to improve retention and suppression","ClinicalTrials.gov (EAPoC-VL)"
NCT06176859,T-CT-004,"Delivery Optimization for Pre-Exposure Prophylaxis (Decentralized service delivery)","Implementation / Randomized","Multi-site (decentralized delivery)","Programmatic / implementation partner","At-risk individuals eligible for PrEP per local guidelines; Age >= site-specific","Contraindication to PrEP; Enrolled in conflicting trial","Decentralized home/remote delivery model for PrEP","ClinicalTrials.gov (Decentralized PrEP delivery)"
NCT05333679,T-CT-005,"Urine Tenofovir Point-of-care Test to Identify Patients in TDF-based regimens","Randomized / Diagnostic evaluation","Multi-site (including African sites)","Academic / public health partner","People taking TDF-based ART; Age: adult (site-specific)","Not on TDF-based regimen; Unable to provide specimen","Diagnostic PoC test for adherence; remote monitoring DCT use-case","ClinicalTrials.gov (Urine Tenofovir PoC)"